Evotec AG Acquires KINAXO Biotechnologies, Expanding Its Drug Discovery Platform With Cutting-Edge Technologies

Published: Feb 09, 2011

HAMBURG, Germany, Feb. 9, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced the signing of a definitive agreement to acquire all shares in Kinaxo Biotechnologies GmbH, a Munich-based drug discovery alliance company supporting the development of targeted drugs.

Back to news